A recent Missouri Court of Appeals ruling will reduce taxes on marijuana products in St. Louis County, following a decision that prohibits local governments from layering additional cannabis taxes on top of one another.

The ruling clarifies that while local governments can impose a 3% cannabis tax, the state constitution prevents cities and counties from stacking those local taxes. Under the law, a locality cannot impose multiple local taxes on the same product.

According to the Missouri Independent, 90 of Missouri’s 114 counties have added a 3% local cannabis tax on top of the state’s 14.98% sales tax. However, in 74 of those counties, individual cities or towns have also levied their own 3% tax on top of the county tax. This practice was at the center of the legal challenge, with the appeals court declaring it unconstitutional.
Continue reading

For the third consecutive month marijuana sales in Vermont topped $12 million.

July was the first month in Vermont where marijuana sales reached $12 million. In the months since, the market has maintained sales levels above $12 million.

According to the Vermont Department of Taxes, there was $12.08 million in marijuana and marijuana products sold in September, a decrease from the $13 million sold in August, but a substantial increase from the $10.4 million sold last September. September sales resulted in $1.7 million in tax revenue.
Continue reading

 Custom Cones USA, the company behind the smoking accessories brands DaySavers, Smoke Temple, and Fill-a Blunts, today published a white paper in partnership with Headset that provides the deepest analysis of the cannabis industry pre-roll consumer, looking at everything from demographics, purchasing behaviors, consumer preferences, and price points.

The report found that Millennials account for the largest share of pre-roll purchases by nearly 100%, cornering 45% of market demand at $104 million. In a first-of-its-kind study, they combined survey data from over 900 cannabis users from around the country with Headset analytics to create a comprehensive look at the pre-roll consumer and their buying habits.

What the report found is that pre-roll use continues to rise, with 82% of consumers buying them, and sales revenue is up over 450% over the past 5 years at $3 billion. It also found that consumers have a wide variety of preferences including size and package type, and that more and more are buying premium options like infused pre-rolls (70% of respondents), or pre-rolls with premium filter tips (nearly 60% of respondents). Other notable findings include:

Continue reading

In Michigan, licensed marijuana stores sold nearly $270 million worth of product in October.

In October, marijuana and marijuana products generated $269,527,217.05 in sales, according to data from the Michigan Cannabis Regulatory Agency (CRA). Nearly all sales were for recreational marijuana, with approximately $1 million coming from medical marijuana. These figures represent a slight increase from the $265 million recorded in September and the $262 million in October 2023.

The year-to-date total for marijuana sales in Michigan is now $2.5 billion. All-time sales are now $9,676,325,456.65, putting the state on track to cross $10 billion in mid-December. All-time sales have resulted in over $1.5 billion in tax revenue.
Continue reading

Maryland has continued its strong marijuana sales trend with over $95 million sold in October.

According to data released by the Maryland Cannabis Administration, there was $96,122,126 worth of marijuana and marijuana products sold legally in October, a slight increase from the $93 million sold in September. Sales data includes dried marijuana flower and prerolls, as well as a variety of marijuana products including marijuana concentrates, edibles and topicals. Of the $96 million sold, $71 million was purchased for recreational use, with medical marijuana patients purchasing $25 million in product.

The year-to-date total for marijuana sales in Maryland is now $944 million, putting the state on track to pass the $1 billion mark in November. The top month for the year reminds August, with $100.6 million in marijuana sales.
Continue reading

Illinois is investing $7 million in a new Cannabis Research Institute (CRI) to examine marijuana’s effects on individuals and communities.

The funding, from the state’s Department of Human Services, will support the institute’s mission to provide comprehensive research on the scientific and socio-economic impacts of cannabis use and production.

The CRI, set to be led by Reginald “Reggie” Guadino, will operate from the University of Illinois’ Discovery Partners Institute in Chicago. It is temporarily located at the Illinois Medical Center, previously used as a COVID-19 testing site on the city’s West Side.
Continue reading

Cannabis Bioscience International Holdings (OTCMKTS: CBIH) announce recently that it was selected from a competitive field of numerous companies as one of the few U.S. bioscience cannabis companies invited to participate in the DEA hearings on the rescheduling of marijuana.

Represented by CEO, Mr. Dante Picazo, CBIH will present clinical trial data showcasing the therapeutic benefits and potential of Cannabis sativa L., emphasizing the company’s commitment to pioneering innovative treatments. In its presentation, CBIH will provide robust evidence on the safety and efficacy of cannabis compounds in medical science, while highlighting the economic opportunities a rescheduling could unlock for the entire industry, according to a press release.

“This opportunity reaffirms the importance of advancing cannabinoid research and development. The event provides a vital forum where regulatory authorities can engage directly with entrepreneurs, executives, physicians, scientists, patients, and other key industry stakeholders. Such interaction paves the way for a more informed and equitable regulatory framework for the sector,” says Mr. John Jones, Treasurer and Director of CBIH.
Continue reading